These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 29578532

  • 21. Helios+ and Helios- Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires.
    Thornton AM, Lu J, Korty PE, Kim YC, Martens C, Sun PD, Shevach EM.
    Eur J Immunol; 2019 Mar; 49(3):398-412. PubMed ID: 30620397
    [Abstract] [Full Text] [Related]

  • 22. Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery.
    Paiva RS, Lino AC, Bergman ML, Caramalho I, Sousa AE, Zelenay S, Demengeot J.
    Proc Natl Acad Sci U S A; 2013 Apr 16; 110(16):6494-9. PubMed ID: 23576744
    [Abstract] [Full Text] [Related]

  • 23. GPA33: A Marker to Identify Stable Human Regulatory T Cells.
    Opstelten R, de Kivit S, Slot MC, van den Biggelaar M, Iwaszkiewicz-Grześ D, Gliwiński M, Scott AM, Blom B, Trzonkowski P, Borst J, Cuadrado E, Amsen D.
    J Immunol; 2020 Jun 15; 204(12):3139-3148. PubMed ID: 32366581
    [Abstract] [Full Text] [Related]

  • 24. Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates.
    Tang M, Jia F, Nan F, Zuo F, Yuan Z, Zhang D.
    Front Immunol; 2022 Jun 15; 13():883560. PubMed ID: 35432378
    [Abstract] [Full Text] [Related]

  • 25. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
    Takeda I, Ine S, Killeen N, Ndhlovu LC, Murata K, Satomi S, Sugamura K, Ishii N.
    J Immunol; 2004 Mar 15; 172(6):3580-9. PubMed ID: 15004159
    [Abstract] [Full Text] [Related]

  • 26. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
    Xiao X, Kroemer A, Gao W, Ishii N, Demirci G, Li XC.
    J Immunol; 2008 Sep 01; 181(5):3193-201. PubMed ID: 18713990
    [Abstract] [Full Text] [Related]

  • 27. OX40, OX40L and Autoimmunity: a Comprehensive Review.
    Webb GJ, Hirschfield GM, Lane PJ.
    Clin Rev Allergy Immunol; 2016 Jun 01; 50(3):312-32. PubMed ID: 26215166
    [Abstract] [Full Text] [Related]

  • 28. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
    Kitamura N, Murata S, Ueki T, Mekata E, Reilly RT, Jaffee EM, Tani T.
    Int J Cancer; 2009 Aug 01; 125(3):630-8. PubMed ID: 19455675
    [Abstract] [Full Text] [Related]

  • 29. A two-step process for thymic regulatory T cell development.
    Lio CW, Hsieh CS.
    Immunity; 2008 Jan 01; 28(1):100-11. PubMed ID: 18199417
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J, Feng L, Sun G, Chen P, Zhou Y, Xia M, Li H, Li Y.
    Immunobiology; 2015 Apr 01; 220(4):510-7. PubMed ID: 25468562
    [Abstract] [Full Text] [Related]

  • 32. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells.
    Mahmud SA, Manlove LS, Schmitz HM, Xing Y, Wang Y, Owen DL, Schenkel JM, Boomer JS, Green JM, Yagita H, Chi H, Hogquist KA, Farrar MA.
    Nat Immunol; 2014 May 01; 15(5):473-81. PubMed ID: 24633226
    [Abstract] [Full Text] [Related]

  • 33. Single-Cell Transcriptomics Reveals Discrete Steps in Regulatory T Cell Development in the Human Thymus.
    Morgana F, Opstelten R, Slot MC, Scott AM, van Lier RAW, Blom B, Mahfouz A, Amsen D.
    J Immunol; 2022 Jan 15; 208(2):384-395. PubMed ID: 34937744
    [Abstract] [Full Text] [Related]

  • 34. CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.
    St Rose MC, Taylor RA, Bandyopadhyay S, Qui HZ, Hagymasi AT, Vella AT, Adler AJ.
    Immunol Cell Biol; 2013 Feb 15; 91(2):173-83. PubMed ID: 23295363
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
    Metzger TC, Long H, Potluri S, Pertel T, Bailey-Bucktrout SL, Lin JC, Fu T, Sharma P, Allison JP, Feldman RM.
    Cancer Res; 2016 Jul 01; 76(13):3684-9. PubMed ID: 27197182
    [Abstract] [Full Text] [Related]

  • 38. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
    Xiao X, Gong W, Demirci G, Liu W, Spoerl S, Chu X, Bishop DK, Turka LA, Li XC.
    J Immunol; 2012 Jan 15; 188(2):892-901. PubMed ID: 22147766
    [Abstract] [Full Text] [Related]

  • 39. Thymic origins of autoimmunity-lessons from inborn errors of immunity.
    Bacchetta R, Weinberg K.
    Semin Immunopathol; 2021 Feb 15; 43(1):65-83. PubMed ID: 33532929
    [Abstract] [Full Text] [Related]

  • 40. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC, Zhang AH, Yoon J, Culp WE, Lees JR, Wucherpfennig KW, Scott DW.
    J Autoimmun; 2018 Aug 15; 92():77-86. PubMed ID: 29857928
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.